Ammonia impairs glutamatergic communication in astroglial cells: Protective role of resveratrol

Toxicology in Vitro

Volumn 29, Issue 8, 2015, Pages 2022-2029

  Bobermin, Larissa Daniele ^a   Hansel, Gisele ^a   Scherer, Emilene B S ^a   Wyse, Angela T S ^a   Souza, Diogo Onofre ^a   Quincozes Santos, André ^a   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Ammonia; C6 Astroglial cells; Glutamate; Resveratrol

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMMONIA; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMIC ACID; GLUTATHIONE; HEME OXYGENASE 1; RESVERATROL; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1; GLUTAMATE AMMONIA LIGASE; SLC1A1 PROTEIN, RAT; STILBENE DERIVATIVE;

AMINO ACID TRANSPORT; ARTICLE; ASTROCYTE; CELL COMMUNICATION; CELL LEVEL; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; NEUROPROTECTION; PROTEIN EXPRESSION; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RAT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMMONIA; ANIMALS; ASTROCYTES; CELL LINE, TUMOR; EXCITATORY AMINO ACID TRANSPORTER 3; GENE EXPRESSION REGULATION; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; RATS; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; STILBENES;

EID: 84941285095     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.08.008     Document Type: Article

References (88)

1. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 2008, 60:79-127. 10.1124/pr.107.07104.
2. Albrecht J., Jones E.A. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci. 1999, 170:138-146.
3. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
4. Banerjee R., Vitvitsky V., Garg S.K. The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends Biochem. Sci. 2008, 33:413-419. 10.1016/j.tibs.2008.06.006.
5. Bastianetto S., Quirion R. Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp. Neurol. 2010, 225:237-239. 10.1016/j.expneurol.2010.06.019.
6. Bastianetto S., Ménard C., Quirion R. Neuroprotective action of resveratrol. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2014, 10.1016/j.bbadis.2014.09.011.
7. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506. 10.1038/nrd2060.
8. Bélanger M., Allaman I., Magistretti P.J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011, 14:724-738. 10.1016/j.cmet.2011.08.016.
9. Bobermin L.D., Quincozes-Santos A., Guerra M.C., Leite M.C., Souza D.O., Gonçalves C.-A., Gottfried C. Resveratrol prevents ammonia toxicity in astroglial cells. PLoS One 2012, 7. 10.1371/journal.pone.0052164.
10. - co-transporter and PKC pathway. Toxicol. In Vitro 2013, 27:2041-2048. 10.1016/j.tiv.2013.07.006.
11. Basic Neurochemistry: Principles of Molecular, Cellular, and Medical Neurobiology 2012, Elsevier/Academic Press, Amsterdam; Boston. 8th ed. S.T. Brady, G.J. Siegel, R.W. Albers, D.L. Price, J. Benjamins (Eds.).
12. Browne R.W., Armstrong D. Reduced glutathione and glutathione disulfide. Methods Mol. Biol. Clifton NJ 1998, 108:347-352. 10.1385/0-89603-472-0:347.
13. Butterworth R.F. Pathophysiology of brain dysfunction in hyperammonemic syndromes: the many faces of glutamine. Mol. Genet. Metab. 2014, 113:113-117. 10.1016/j.ymgme.2014.06.003.
14. Butterworth R.F. Pathophysiology of brain dysfunction in hyperammonemic syndromes: the many faces of glutamine. Mol. Genet. Metab. 2014, 113:113-117. 10.1016/j.ymgme.2014.06.003.
15. Butz M., May E.S., Häussinger D., Schnitzler A. The slowed brain: cortical oscillatory activity in hepatic encephalopathy. Arch. Biochem. Biophys. 2013, 536:197-203. 10.1016/j.abb.2013.04.004.
16. Calabrese V., Ravagna A., Colombrita C., Scapagnini G., Guagliano E., Calvani M., Butterfield D.A., Giuffrida Stella A.M. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J. Neurosci. Res. 2005, 79:509-521. 10.1002/jnr.20386.
17. Chan K.M., Delfert D., Junger K.D. A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal. Biochem. 1986, 157:375-380.
18. Currais A., Maher P. Functional consequences of age-dependent changes in glutathione status in the brain. Antioxid. Redox Signal. 2013, 19:813-822. 10.1089/ars.2012.4996.
19. Dai H., Song D., Xu J., Li B., Hertz L., Peng L. Ammonia-induced Na, K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling. Neurochem. Int. 2013, 63:610-625. 10.1016/j.neuint.2013.09.005.
20. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
21. Davis K.E., Straff D.J., Weinstein E.A., Bannerman P.G., Correale D.M., Rothstein J.D., Robinson M.B. Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. J. Neurosci. Off. J. Soc. Neurosci. 1998, 18:2475-2485.
22. De Almeida L.M.V., Piñeiro C.C., Leite M.C., Brolese G., Tramontina F., Feoli A.M., Gottfried C., Gonçalves C.-A. Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell. Mol. Neurobiol. 2007, 27:661-668. 10.1007/s10571-007-9152-2.
23. Dos Santos A.Q., Nardin P., Funchal C., de Almeida L.M.V., Jacques-Silva M.C., Wofchuk S.T., Gonçalves C.-A., Gottfried C. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch. Biochem. Biophys. 2006, 453:161-167. 10.1016/j.abb.2006.06.025.
24. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 2000, 62:649-671.
25. Esposito E., Iacono A., Muià C., Crisafulli C., Mattace Raso G., Bramanti P., Meli R., Cuzzocrea S. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J. Pineal Res. 2008, 44:78-87. 10.1111/j.1600-079X.2007.00492.x.
26. Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat. Rev. Neurosci. 2013, 14:851-858. 10.1038/nrn3587.
27. Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog. Neurobiol. 2002, 67:259-279. 10.1016/S0301-0082(02)00019-9.
28. Ferreira A.G.K., Stefanello F.M., Cunha A.A., da Cunha M.J., Pereira T.C.B., Bonan C.D., Bogo M.R., Netto C.A., Wyse A.T.S. Role of antioxidants on Na(+), K (+)-ATPase activity and gene expression in cerebral cortex of hyperprolinemic rats. Metab. Brain Dis. 2011, 26:141-147. 10.1007/s11011-011-9243-0.
29. Görg B., Morwinsky A., Keitel V., Qvartskhava N., Schrör K., Häussinger D. Ammonia triggers exocytotic release of l-glutamate from cultured rat astrocytes. Glia 2010, 58:691-705. 10.1002/glia.20955.
30. Görg B., Schliess F., Häussinger D. Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy. Arch. Biochem. Biophys. 2013, 536:158-163. 10.1016/j.abb.2013.03.010.
31. Görg B., Karababa A., Shafigullina A., Bidmon H.J., Häussinger D. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Glia 2014, 10.1002/glia.22731.
32. Grisar T., Guillaume D., Delgado-Escueta A.V. Contribution of Na+, K(+)-ATPase to focal epilepsy: a brief review. Epilepsy Res. 1992, 12:141-149.
33. Haas M., Forbush B. The Na-K-Cl cotransporters. J. Bioenerg. Biomembr. 1998, 30:161-172.
34. Haines D.D., Lekli I., Teissier P., Bak I., Tosaki A. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol (Oxf.) 2012, 204:487-501. 10.1111/j.1748-1716.2011.02387.x.
35. Häussinger D. Hepatic encephalopathy. Acta Gastro-Enterol. Belg. 2010, 73:457-464.
36. Hertz L., Peng L., Song D. Ammonia, Like K(+), stimulates the Na(+), K(+), 2 Cl(-) cotransporter NKCC1 and the Na(+), K(+)-ATPase and interacts with endogenous ouabain in astrocytes. Neurochem. Res. 2014, 10.1007/s11064-014-1352-9.
37. Jayakumar A.R., Norenberg M.D. The Na-K-Cl Co-transporter in astrocyte swelling. Metab. Brain Dis. 2010, 25:31-38. 10.1007/s11011-010-9180-3.
38. Jayakumar A.R., Liu M., Moriyama M., Ramakrishnan R., Forbush B., Reddy P.V.B., Norenberg M.D. Na-K-Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling. J. Biol. Chem. 2008, 283:33874-33882. 10.1074/jbc.M804016200.
39. Jayakumar A.R., Liu M., Moriyama M., Ramakrishnan R., Forbush B., Reddy P.V.B., Norenberg M.D. Na-K-Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling. J. Biol. Chem. 2008, 283:33874-33882. 10.1074/jbc.M804016200.
40. Joseph M.H., Marsden C.A. Amino acids and small peptides. HPLC of Small Peptides 1986, 13-27. IRL Press, Oxford. C.K. Lim (Ed.).
41. +-ATPase activity, increase in potassium uptake, and enhanced production of ouabain-like compounds in ammonia-treated mouse astrocytes. Neurochem. Int. 2000, 36:203-211.
42. Kelly T., Rose C.R. Ammonium influx pathways into astrocytes and neurones of hippocampal slices. J. Neurochem. 2010, 115:1123-1136. 10.1111/j.1471-4159.2010.07009.x.
43. Kelly T., Kafitz K.W., Roderigo C., Rose C.R. Ammonium-evoked alterations in intracellular sodium and pH reduce glial glutamate transport activity. Glia 2009, 57:921-934. 10.1002/glia.20817.
44. Kosenko E., Kaminsky Y., Grau E., Miñana M.D., Marcaida G., Grisolía S., Felipo V. Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and Na+, K(+)-ATPase. J. Neurochem. 1994, 63:2172-2178.
45. Kulkarni S.S., Cantó C. The molecular targets of resveratrol. Biochim. Biophys. Acta 2014, 10.1016/j.bbadis.2014.10.005.
46. Kumar A., Negi G., Sharma S.S. Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms. Curr. Med. Chem. 2013, 20:4640-4645.
47. Lee M., Cho T., Jantaratnotai N., Wang Y.T., McGeer E., McGeer P.L. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB 2010, 24:2533-2545. 10.1096/fj.09-149997.
48. Lee J.-C., Kim I.H., Park J.H., Ahn J.H., Cho J.-H., Cho G.-S., Tae H.-J., Chen B.H., Yan B.C., Yoo K.-Y., Choi J.H., Lee C.H., Hwang I.K., Cho J.H., Kwon Y.-G., Kim Y.-M., Won M.-H. Ischemic preconditioning protects hippocampal pyramidal neurons from transient ischemic injury via the attenuation of oxidative damage through upregulating heme oxygenase-1. Free Radic. Biol. Med. 2015, 79:78-90. 10.1016/j.freeradbiomed.2014.11.022.
49. +-dependent glutamate uptake. J. Neurosci. Off. J. Soc. Neurosci. 1998, 18:9620-9628.
50. Li M.-H., Jang J.-H., Na H.-K., Cha Y.-N., Surh Y.-J. Carbon monoxide produced by heme oxygenase-1 in response to nitrosative stress induces expression of glutamate-cysteine ligase in PC12 cells via activation of phosphatidylinositol 3-kinase and Nrf2 signaling. J. Biol. Chem. 2007, 282:28577-28586. 10.1074/jbc.M701916200.
51. Lingrel J.B. Na, K-ATPase: isoform structure, function, and expression. J. Bioenerg. Biomembr. 1992, 24:263-270.
52. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
53. Malarkey E.B., Parpura V. Mechanisms of glutamate release from astrocytes. Neurochem. Int. 2008, 52:142-154. 10.1016/j.neuint.2007.06.005.
54. Matés J.M., Pérez-Gómez C., Núñez de Castro I., Asenjo M., Márquez J. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int. J. Biochem. Cell Biol. 2002, 34:439-458.
55. McKenna M.C. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J. Neurosci. Res. 2007, 85:3347-3358. 10.1002/jnr.21444.
56. Monfort P., Kosenko E., Erceg S., Canales J.-J., Felipo V. Molecular mechanism of acute ammonia toxicity: role of NMDA receptors. Neurochem. Int. 2002, 41:95-102. 10.1016/S0197-0186(02)00029-3.
57. Montana V., Verkhratsky A., Parpura V. Pathological role for exocytotic glutamate release from astrocytes in hepatic encephalopathy. Curr. Neuropharmacol. 2014, 12:324-333. 10.2174/1570159X12666140903094700.
58. Norenberg M.D., Rama Rao K.V., Jayakumar A.R. Signaling factors in the mechanism of ammonia neurotoxicity. Metab. Brain Dis. 2009, 24:103-117. 10.1007/s11011-008-9113-6.
59. Ohara K., Aoyama M., Fujita M., Sobue K., Asai K. Prolonged exposure to ammonia increases extracellular glutamate in cultured rat astrocytes. Neurosci. Lett. 2009, 462:109-112. 10.1016/j.neulet.2009.06.090.
60. Park E.-J., Pezzuto J.M. The pharmacology of resveratrol in animals and humans. Biochim. Biophys. Acta 2015, 10.1016/j.bbadis.2015.01.014.
61. Parpura V., Verkhratsky A. Astrocytes revisited: concise historic outlook on glutamate homeostasis and signaling. Croat. Med. J. 2012, 53:518-528. 10.3325/cmj.2012.53.518.
62. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J. 2003, 17:1975-1985. 10.1096/fj.03-0168rev.
63. Quan S., Yang L., Shnouda S., Schwartzman M.L., Nasjletti A., Goodman A.I., Abraham N.G. Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury. Kidney Int. 2004, 65:1628-1639. 10.1111/j.1523-1755.2004.00562.x.
64. Quincozes-Santos A., Gottfried C. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann. N. Y. Acad. Sci. 2011, 1215:72-78. 10.1111/j.1749-6632.2010.05857.x.
65. Quincozes-Santos A., Bobermin L.D., Latini A., Wajner M., Souza D.O., Gonçalves C.-A., Gottfried C. Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1. PLoS One 2013, 8. 10.1371/journal.pone.0064372.
66. Quincozes-Santos A., Bobermin L.D., Souza D.G., Bellaver B., Gonçalves C.-A., Souza D.O. Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1. J. Neurochem. 2014, 130:61-74. 10.1111/jnc.12694.
67. Quincozes-Santos A., Bobermin L.D., Tramontina A.C., Wartchow K.M., Tagliari B., Souza D.O., Wyse A.T.S., Gonçalves C.-A. Oxidative stress mediated by NMDA AMPA/KA channels in acute hippocampal slices: neuroprotective effect of resveratrol. Toxicol. Vitro Int. J. Publ. Assoc. BIBRA 2014, 28:544-551. 10.1016/j.tiv.2013.12.021.
68. Raederstorff D., Kunz I., Schwager J. Resveratrol, from experimental data to nutritional evidence: the emergence of a new food ingredient. Ann. N. Y. Acad. Sci. 2013, 1290:136-141. 10.1111/nyas.12147.
69. Rama Rao K.V., Chen M., Simard J.M., Norenberg M.D. Suppression of ammonia-induced astrocyte swelling by cyclosporin A. J. Neurosci. Res. 2003, 74:891-897. 10.1002/jnr.10755.
70. Rege S.D., Geetha T., Griffin G.D., Broderick T.L., Babu J.R. Neuroprotective effects of resveratrol in Alzheimer disease pathology. Front. Aging Neurosci. 2014, 6:218. 10.3389/fnagi.2014.00218.
71. Robert S.M., Ogunrinu-Babarinde T., Holt K.T., Sontheimer H. Role of glutamate transporters in redox homeostasis of the brain. Neurochem. Int. 2014, 73:181-191. 10.1016/j.neuint.2014.01.001.
72. Rose C. Effect of ammonia on astrocytic glutamate uptake/release mechanisms. J. Neurochem. 2006, 97:11-15. 10.1111/j.1471-4159.2006.03796.x.
73. Rose C., Kresse W., Kettenmann H. Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J. Biol. Chem. 2005, 280:20937-20944. 10.1074/jbc.M412448200.
74. Sakata Y., Zhuang H., Kwansa H., Koehler R.C., Doré S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol. 2010, 224:325-329. 10.1016/j.expneurol.2010.03.032.
75. 2+-dependent glutamate release. Neuroscience 2009, 158:253-259. 10.1016/j.neuroscience.2008.03.039.
76. Scapagnini G., Butterfield D.A., Colombrita C., Sultana R., Pascale A., Calabrese V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid. Redox Signal. 2004, 6:811-818. 10.1089/ars.2004.6.811.
77. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. FEBS 2000, 267:4904-4911.
78. Shaked I., Ben-Dror I., Vardimon L. Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina. J. Neurochem. 2002, 83:574-580.
79. Simão F., Matté A., Matté C., Soares F.M.S., Wyse A.T.S., Netto C.A., Salbego C.G. Resveratrol prevents oxidative stress and inhibition of Na(+)K(+)-ATPase activity induced by transient global cerebral ischemia in rats. J. Nutr. Biochem. 2011, 22:921-928. 10.1016/j.jnutbio.2010.07.013.
80. Son Y., Lee J.H., Chung H.-T., Pae H.-O. Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid. Med. Cell. Longev. 2013, 2013:639541. 10.1155/2013/639541.
81. +-ATPase activity in rat hippocampus: prevention by antioxidants. Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci. 2011, 29:483-488. 10.1016/j.ijdevneu.2011.02.001.
82. Steiner J., Schroeter M.L., Schiltz K., Bernstein H.G., Müller U.J., Richter-Landsberg C., Müller W.E., Walter M., Gos T., Bogerts B., Keilhoff G. Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience 2010, 167:1025-1031. 10.1016/j.neuroscience.2010.03.010.
83. Swain M., Butterworth R.F., Blei A.T. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatol. Baltim. Md 1992, 15:449-453.
84. Syapin P.J. Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders: regulating HO-1 in the CNS. Br. J. Pharmacol. 2009, 155:623-640. 10.1038/bjp.2008.342.
85. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?. Trends Pharmacol. Sci. 1998, 19:328-334.
86. +-ATPase activity in cerebral cortex of rats. Neuroreport 2000, 11:2331-2334.
87. Zeng T., Zhang C.-L., Song F.-Y., Zhao X.-L., Yu L.-H., Zhu Z.-P., Xie K.-Q. The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress. Biochim. Biophys. Acta 2013, 1830:4848-4859. 10.1016/j.bbagen.2013.06.028.
88. Zou J., Wang Y.-X., Dou F.-F., Lü H.-Z., Ma Z.-W., Lu P.-H., Xu X.-M. Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem. Int. 2010, 56:577-584. 10.1016/j.neuint.2009.12.021.